Literature DB >> 24335748

Psychometric validation of the Confidence in Performing Sexual Intercourse Questionnaire and Difficulty in Performing Sexual Intercourse Questionnaire.

R P Hayes1, A Seftel2, R C Rosen3, S Althof4, W Shen1, T Shih5, A Sontag6.   

Abstract

The objective of this study was to perform psychometric testing of two new patient-reported outcome instruments (PROs), the Confidence in Performing Sexual Intercourse Questionnaire (CPSIQ) and the Difficulty in Performing Sexual Intercourse Questionnaire (DPSIQ). The new PROs were administered at non-drug, run-in, baseline and end point in men with erectile dysfunction (ED) participating in a randomized clinical trial of ED treatment (Study 1, n=291) and two times within 2 weeks to men with ED participating in a web-based survey (Study 2, n=71). Psychometric tests included factor analysis, internal consistency and test-retest reliability, construct validity and responsiveness. Analysis of data from Study 1 participants (74% ≤65 years, 83% Caucasian and 75% with moderate ED) suggested one-factor solutions for both PROs with Cronbach's α >0.88. CPSIQ and DPSIQ total scores discriminated between ED severity groups showed worsening after a 4-week non-drug, run-in period, and showed improvement after 12 weeks of ED treatment (all, P<0.05). Intraclass correlation coefficients calculated for the CPSIQ and DPSIQ, using data from Study 2 participants (82% ≤65 years, 90% Caucasian and 66% with mild ED), were 0.56 and 0.83, respectively. The CPSIQ and DPSIQ show potential for augmenting existing treatment outcome measures used in the evaluation of ED treatment.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24335748     DOI: 10.1038/ijir.2013.45

Source DB:  PubMed          Journal:  Int J Impot Res        ISSN: 0955-9930            Impact factor:   2.896


  14 in total

1.  The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction.

Authors:  R C Rosen; A Riley; G Wagner; I H Osterloh; J Kirkpatrick; A Mishra
Journal:  Urology       Date:  1997-06       Impact factor: 2.649

2.  Minimal clinically important differences in the vaginal insertion and successful intercourse items of the sexual encounter profile.

Authors:  Andre B Araujo; Kerstin R Allen; Xiao Ni; Raymond C Rosen
Journal:  J Sex Med       Date:  2011-10-07       Impact factor: 3.802

3.  A methodological framework for assessing health indices.

Authors:  B Kirshner; G Guyatt
Journal:  J Chronic Dis       Date:  1985

4.  Perceptions and opinions of men and women on a man's sexual confidence and its relationship to ED: results of the European Sexual Confidence Survey.

Authors:  C San Martín; C Simonelli; J Sønksen; G Schnetzler; S Patel
Journal:  Int J Impot Res       Date:  2012-06-21       Impact factor: 2.896

5.  Longitudinal differences in psychological outcomes for men with erectile dysfunction: results from ExCEED.

Authors:  David M Latini; David F Penson; Katrine L Wallace; Deborah P Lubeck; Tom F Lue
Journal:  J Sex Med       Date:  2006-11       Impact factor: 3.802

6.  A typology of men's sexual attitudes, erectile dysfunction treatment expectations and barriers.

Authors:  M M Berner; W Plöger; M Burkart
Journal:  Int J Impot Res       Date:  2007-08-23       Impact factor: 2.896

Review 7.  An assessment of patient-reported outcomes for men with erectile dysfunction: Pfizer's perspective.

Authors:  J C Cappelleri; V J Stecher
Journal:  Int J Impot Res       Date:  2008-03-27       Impact factor: 2.896

8.  Development and validation of the Self-Esteem And Relationship (SEAR) questionnaire in erectile dysfunction.

Authors:  J C Cappelleri; S E Althof; R L Siegel; A Shpilsky; S S Bell; S Duttagupta
Journal:  Int J Impot Res       Date:  2004-02       Impact factor: 2.896

9.  Establishing the content validity of the confidence in performing sexual intercourse and difficulty in performing sexual intercourse questionnaires.

Authors:  R P Hayes; J Henne; M L Meldahl; A Sontag
Journal:  Int J Impot Res       Date:  2013-05-02       Impact factor: 2.896

10.  A return to normal erectile function with tadalafil once daily after an incomplete response to as-needed PDE5 inhibitor therapy.

Authors:  Edward D Kim; Allen D Seftel; Evan R Goldfischer; Xiao Ni; Patrick R Burns
Journal:  J Sex Med       Date:  2013-07-10       Impact factor: 3.802

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.